| Literature DB >> 27067838 |
Anders E Bilgrau1,2, Steffen Falgreen3, Anders Petersen3, Malene K Kjeldsen3, Julie S Bødker3, Hans E Johnsen3,4, Karen Dybkær3,4, Martin Bøgsted3,4.
Abstract
BACKGROUND: Accurate adjustment for the amplification efficiency (AE) is an important part of real-time quantitative polymerase chain reaction (qPCR) experiments. The most commonly used correction strategy is to estimate the AE by dilution experiments and use this as a plug-in when efficiency correcting the Δ Δ C q . Currently, it is recommended to determine the AE with high precision as this plug-in approach does not account for the AE uncertainty, implicitly assuming an infinitely precise AE estimate. Determining the AE with such precision, however, requires tedious laboratory work and vast amounts of biological material. Violation of the assumption leads to overly optimistic standard errors of the Δ Δ C q , confidence intervals, and p-values which ultimately increase the type I error rate beyond the expected significance level. As qPCR is often used for validation it should be a high priority to account for the uncertainty of the AE estimate and thereby properly bounding the type I error rate and achieve the desired significance level.Entities:
Keywords: Amplification efficiency; Delta-delta Cq; Efficiency adjusted; Error propagation; qPCR; Δ Δ C q
Mesh:
Substances:
Year: 2016 PMID: 27067838 PMCID: PMC4827196 DOI: 10.1186/s12859-016-0997-6
Source DB: PubMed Journal: BMC Bioinformatics ISSN: 1471-2105 Impact factor: 3.169
Fig. 1Overview of CIC experiment data. a Raw C -values for different cell lines (samples) for each gene type and sample type. The point type and colour differentiates the different gene types. b Dilution data for reference genes (ACTB, GAPDH) and target genes (MGST1, MMSET)
CIC data: Method comparison for estimating the Δ Δ C -value
| Estimate | se |
| df |
| LCL | UCL | |
|---|---|---|---|---|---|---|---|
| MGST1 vs GAPDH | |||||||
| EC | –8.62 | 1.62 | –5.31 | 21 | 2.92·10−5 | –12 | –5.24 |
| EC&VA1 | –8.62 | 1.66 | –5.18 | 21 | 3.89·10−5 | –12.1 | –5.16 |
| EC&VA2 | –8.62 | 1.67 | –5.17 | 21 | 4.04·10−5 | –12.1 | –5.15 |
| Bootstrap | –8.66 | 2.06 | 1.00·10−3 | –12.5 | –4.41 | ||
| MGST1 vs ACTB | |||||||
| EC | –8.98 | 1.61 | –5.57 | 21 | 1.57·10−5 | –12.3 | –5.63 |
| EC&VA1 | –8.98 | 1.65 | –5.45 | 21 | 2.08·10−5 | –12.4 | –5.56 |
| EC&VA2 | –8.98 | 1.65 | –5.45 | 21 | 2.10·10−5 | –12.4 | –5.55 |
| Bootstrap | –8.98 | 2.09 | 1.00·10−3 | –12.7 | –4.48 | ||
| MMSET vs GAPDH | |||||||
| EC | 0.679 | 0.585 | 1.16 | 21 | 2.59·10−1 | –0.538 | 1.9 |
| EC&VA1 | 0.679 | 0.587 | 1.16 | 21 | 2.60·10−1 | –0.541 | 1.9 |
| EC&VA2 | 0.679 | 0.589 | 1.15 | 21 | 2.62·10−1 | –0.545 | 1.9 |
| Bootstrap | 0.688 | 0.678 | 3.12·10−1 | –0.656 | 2 | ||
| MMSET vs ACTB | |||||||
| EC | 0.318 | 0.962 | 0.331 | 21 | 7.44·10−1 | –1.68 | 2.32 |
| EC&VA1 | 0.318 | 0.962 | 0.331 | 21 | 7.44·10−1 | –1.68 | 2.32 |
| EC&VA2 | 0.318 | 0.964 | 0.33 | 21 | 7.45·10−1 | –1.69 | 2.32 |
| Bootstrap | 0.342 | 0.987 | 7.05·10−1 | –1.68 | 2.13 |
EC efficiency corrected LMM estimate ignoring the uncertainty of the efficiency estimates. EC&VA1 EC and variance adjusted LMM estimate using the delta method. EC&VA2 EC and variance adjusted LMM estimate using Monte Carlo integration. Bootstrap estimate by the bootstrap described in Section “Inference for ” fitting the LMM and using the EC estimate. Bootstrap shows the mean and standard deviation of 2000 bootstrap samples using the EC estimate. The last two columns show the 95 % lower and upper confidence interval limits
Fig. 2Overview of DLBCL testis data. a Raw C -values for different patient samples for each gene type and sample type. The point type and colour differentiates the different gene types. b Dilution data for reference genes (RNU-24, RNU-6B) and target genes (miR-127, miR-143)
DLBCL data: Method comparison for estimating the Δ Δ C -value
| Estimate | se |
| df |
| LCL | UCL | |
|---|---|---|---|---|---|---|---|
| mir127 vs rnu6b | |||||||
| EC | 2.67 | 1.13 | 2.37 | 22 | 2.68·10−2 | 0.336 | 5.01 |
| EC&VA1 | 2.67 | 1.13 | 2.37 | 22 | 2.71·10−2 | 0.331 | 5.01 |
| EC&VA2 | 2.67 | 1.13 | 2.36 | 22 | 2.75·10−2 | 0.325 | 5.02 |
| Bootstrap | 2.68 | 1.05 | 1.00·10−3 | 0.876 | 4.82 | ||
| mir127 vs rnu24 | |||||||
| EC | 2.38 | 1.08 | 2.2 | 22 | 3.87·10−2 | 0.136 | 4.63 |
| EC&VA1 | 2.38 | 1.09 | 2.19 | 22 | 3.91·10−2 | 0.13 | 4.64 |
| EC&VA2 | 2.38 | 1.09 | 2.19 | 22 | 3.94·10−2 | 0.126 | 4.64 |
| Bootstrap | 2.42 | 1.18 | 1.00·10−2 | 0.416 | 5.02 | ||
| mir143 vs rnu6b | |||||||
| EC | 1.17 | 0.846 | 1.38 | 22 | 1.82·10−1 | -0.589 | 2.92 |
| EC&VA1 | 1.17 | 0.846 | 1.38 | 22 | 1.82·10−1 | -0.59 | 2.92 |
| EC&VA2 | 1.17 | 0.847 | 1.37 | 22 | 1.83·10−1 | -0.592 | 2.92 |
| Bootstrap | 1.15 | 0.794 | 1.44·10−1 | -0.341 | 2.7 | ||
| mir143 vs rnu24 | |||||||
| EC | 0.878 | 0.81 | 1.08 | 22 | 2.90·10−1 | -0.801 | 2.56 |
| EC&VA1 | 0.878 | 0.81 | 1.08 | 22 | 2.90·10−1 | -0.802 | 2.56 |
| EC&VA2 | 0.878 | 0.811 | 1.08 | 22 | 2.90·10−1 | -0.803 | 2.56 |
| Bootstrap | 0.897 | 0.822 | 2.67·10−1 | -0.603 | 2.58 |
EC efficiency corrected LMM estimate ignoring the uncertainty of the efficiency estimates. EC&VA1 EC and variance adjusted LMM estimate using the delta method. EC&VA2 EC and variance adjusted LMM estimate using Monte Carlo integration. Bootstrap Estimate by the bootstrap described in Section “Inference for ” fitting the LMM and using the EC estimate. Bootstrap shows the mean and standard deviation of 4 bootstrap samples using the EC estimate. The last two columns show the 95 % lower and upper confidence interval limits
Fig. 3Overview of Arabidopsis thaliana data [7]. C -values against the dilution step for case and control samples. Dilution data are present for both the target (MT7) and reference genes (Tublin, UBQ)
Arabidopsis thaliana data [7]: Method comparison for estimating the Δ Δ C -value
| Estimate | se |
| df |
| LCL | UCL | |
|---|---|---|---|---|---|---|---|
| MT7 vs Tublin | |||||||
| EC | -4.374 | 0.4319 | -10.13 | 4 | 5.353·10−4 | -5.573 | -3.174 |
| EC&VA1 | -4.374 | 3.788 | -1.155 | 4 | 3.126·10−1 | -14.89 | 6.144 |
| MT7 vs UBQ | |||||||
| EC | -3.381 | 0.137 | -24.67 | 4 | 1.601·10−5 | -3.761 | -3 |
| EC&VA1 | -3.381 | 1.351 | -2.503 | 4 | 6.658·10−2 | -7.132 | 0.3699 |
EC efficiency corrected LMM estimate ignoring the uncertainty of the efficiency estimates. EC&VA1 EC and variance adjusted LMM estimate using the delta method. The last two columns show the 952000 lower and upper confidence interval limits
Contingency tables for the different estimators for at 5 % p-value threshold
| EC | EC&VA1 | Bootstr. | ||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |||
|
| ||||||||
|
| 1854 | 1235 | 1894 | 1365 | 1834 | 1268 | ||
|
| 146 | 765 | 106 | 635 | 166 | 732 | ||
The used estimators are the LMM with efficiency correction (EC), the LMM with EC and variance adjustment (EC&VA), and the bootstrapped LMM approach
Fig. 4Method performance. Plot of the false positive rates (FPR, black) and true positive rates (TPR, grey) and their 95 % confidence intervals achieved simulation experiments for each method at various p-value cut-offs (0.05, 0.01, 0.1) shown by solid red horizontal lines. The FPR and TPR are computed completely analogous to Table 4. The rates are plotted for each combination of 4 or 8 samples with 4 or 8 fold dilution curves
Fig. 5Standard error comparison. The mean standard error of the Δ Δ C for two methods (EC and EC&VA1) over 2000 repeated simulations under the null (panel a) and alternative hypothesis (panel b) as a function of the number of dilution steps for a different number of samples in each group